2. Disclaimer
This presentation was prepared in order to provide the general public a an updated overview on
Brazil’s public health trends. The great majority of information contained in this presentation was
originally published by IBGE (Brazilian Institute of Geography and Statistics) and the Brazilian
Ministry of Health and is of public domain. Therefore, the author of this work does not claim
authorship and ownership of any information originally published elsewhere. The resources listed
may direct the reader to local government agencies websites which content is communicated in
Portuguese. The free translation content is made to the best of our knowledge. Therefore, Brazil
Pharma News does not warrant the accuracy, reliability or timeliness of any information translated
in the following slides. In addition, some items may not be fully translated into English, including
graphs, photos or print screen documents. Brazil Pharma News does not endorse the use of any
web translation tools; other translation services may be used to view our site. The information
reported in this presentation does not necessarily reflect our official position on the subject, nor of
any present or past associated employers of the author. Some web links may be time‐sensitive.
These links may move or expire as the news changes throughout the time. Some sources may
require registration or fee‐based subscriptions. Any person or entities that rely on information
obtained from the system does so at his or her own risk. The commercial use or unauthorized
distribution of the contents in this presentation without prior consent is prohibited. If you have any
suggestions or comments, please contact us by using the feedback form available at Contact Us.
Brazil Pharma News
3. Federative Republic of Brazil
• Population: 205 million people (July 2012 est.)
• Total land are: 3,287,597 sq. mi.
• GDP: US$ 2.324 trillion (2011)
• GDP Growth: 2.7% (2011)
• One major official language: Portuguese
• Government: Presidential system,
Constitutional republic, Federal republic
• Population concentration in major urban areas:
São Paulo, Rio de Janeiro, Belo Horizonte, Porto
Alegre, Brasilia.
• Urbanization: 40% metropolitan
• Life expectancy at birth : 74.08 yrs (2011 est.)
• Total health expenditures (2006): US$ 87.3
billion
• Health expenditure as % GDP: 9 (2009)
Sources: World Bank , World Fact Book: Central Intelligence
Agency and IBGE (Brazilian Institute of Geography and Statistics)
4. Basic Health Data Indicators
(IDB) Brazil 2011
The Basic Health Data and Indicators (IDB) are the product of an integrated work led by the PAHO, the
Brazilian Ministry of Health, Institute of Geography and Statistics (IBGE), Institute of Economic Research
(IPEA) and the Ministry of Social Welfare. The IDBs were elaborated by representative technical and
scientific institutions directly involved with the production and analysis of data of interest to national health
systems.
The IDBs presented indicators by regions, states, Federal District and metropolitan areas of city capitals.
Each indicator contains a corresponding qualification sheet designed to guide users in the aspects of
conceptualization, interpretation, uses, limitations, calculation methods and data sources.
The information published at the IBGE web site is the result of joint efforts of dozens of experts linked to
organs and entities of different origins, working in committees, working groups and technical coordination.
DATASUS is responsible to organize all the information, produce the IDB data sheets and generate the
internet reports containing basic data and calculated indicators. The IDB is published on an annual basis
and incorporate improvements corresponding to the progressive improvement of databases.
These IDBs are expected to be utilized in the analysis of current health and trends, subsidizing public
authorities at all levels of management and the social participation in SUS as well as the technical-
scientific community and the instances of political representation in the country.
Source: Indicadores e Dados Básicos - Brasil – 2011 (RIPSA)
5. 2000 169,799,170
2001 172,381,455
2002 174,632,960
2003 176,871,437
2004 181,586,030
2005 184,184,264
2006 186,770,560
2007 189,335,191
2008 189,612,814
2009 191,481,045
2010 190,755,799
Total Population of Brazil
Data analysis: Brazil Pharma News
Data source: IDB (IBGE) Brasil 2011
6. Population distribution by region (2010)
Data analysis: Brazil Pharma News
North
Northeast
14,058,094 Southeast
15,864,454
South
Midwest
27,386,891
53,081,950
80,364,410
Data source: IDB (IBGE) Brasil 2011
7. Gross Birth Rate
Data analysis: Brazil Pharma News
21.23
20.12
19.46
18.83
18.48
17.73
17.08
16.56
16.39
15.98
15.78
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Data source: IDB (IBGE) Brasil 2011
IBGE / Preliminary Demographic Projections
MS / SVS / Born Alive Information System - SINASC
8. 2000 2.36
2001 2.22
2002 2.15
2003 2.08
2004 2.05
2005 2.01
2006 1.95
2007 1.90
2008 1.84
Overall Fertility Rate
2009 1.84
2010 1.82
Data analysis: Brazil Pharma News
Data source: IDB (IBGE) Brasil 2011
9. Fertility rate by year and age group
Data analysis: Brazil Pharma News
0.16000
15 to 19 years
0.14000 20 to 24 years
25 to 29 years
0.12000
30 to 34 years
0.10000 35 to 39 years
40 to 44 years
0.08000
45 to 49 years
0.06000
0.04000
0.02000
‐
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Data source: IDB (IBGE) Brasil 2011
10. 2000 66.7 74.4
2001 67.1 74.7
2002 67.4 75.0
2003 67.7 75.3
2004 68.0 75.6
2005 68.4 75.9
2006 68.7 76.2
2007 68.8 76.4
2008 69.1 76.7
2009 69.4 77.0
2010 69.7 77.3
Life Expectancy at Birth
Men
Women
Data analysis: Brazil Pharma News
Data source: IDB (IBGE) Brasil 2011
11. 2000 28.9
2001 29.8
2002 30.5
2003 31.3
2004 33.0
2005 33.9
2006 32.4
2007 36.2
2008 37.9
2009 39.5
Population Aging Index
2010 44.8
Data analysis: Brazil Pharma News
Data source: IDB (IBGE) Brasil 2011
12. 2000 7.8 9.3
2001 7.9 9.4
2002 8.0 9.5
2003 8.1 9.7
2004 8.2 9.9
2005 8.3 10.0
2006 8.3 9.9
2007 8.7 10.5
2008 9.0 10.8
2009 9.2 11.1
2010 9.8 11.7
Men
Women
Proportion of Elderly Population
Data analysis: Brazil Pharma News
Data source: IDB (IBGE) Brasil 2011
14. Child mortality rate
Data analysis: Brazil Pharma News
North
41.57 Northeast
Southeast
South
Midwest
28.62
20.92 20.97
19.15 19.09
17.03 15.93
13.43
11.58
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Data source: IDB (IBGE) Brasil 2011
15. % Mortality by Age Group in 2010
Data analysis: Brazil Pharma News
80 years or more 25.79
75 a 79 ayears 10.46
70 a 74 years 9.92
65 a 69 years 8.39
60 a 64 years 7.54
55 a 59 years 6.73
50 a 54 years 5.78
45 a 49 years 4.66
40 a 44 years 3.58
35 a 39 years 2.83
30 a 34 years 2.64
25 a 29 years 2.54
20 a 24 years 2.46
15 a 19 years 1.67
10 a 14 years 0.50
5 a 9 years 0.37
1 a 4 years 0.62
Up to 1 year old 3.52
Data source: IDB (IBGE) Brasil 2011
16. % Mortality by Group Causes 2010
Data analysis: Brazil Pharma News
Infectious and parasitic diseases
4.6
Neoplasias
20.5
16.9 Circulatory system diseases
Respiratory system diseases
Perinatal period conditions
External caues
Other defined causes
13.6
2.2
30.9
11.3
Data source: IDB (IBGE) Brasil 2011
17. Circulatory System Diseases Mortality Rate (2010)
Data analysis: Brazil Pharma News
Ischemic heart disease
Cerebrovascular diseases
52
Other circulatory system diseases
66
52
Data source: IDB (IBGE) Brasil 2011
18. Malignant Neoplasm Mortality rate (2010)
Data analysis: Brazil Pharma News
Lung, trachea and bronchi
Esophagus
11.5
Stomach
4.0 Colon, rectum, recto‐sigmoid junction and anus
Female breast
7.0 Cervix
Prostate
46.9
Other locations
7.0
13.1
5.1
13.7
Specific mortality rate: deaths per 100,000 inhabitants. Data source: IDB (IBGE) Brasil 2011
19. Incidence of Malignant Neoplasm by Region
Data analysis: Brazil Pharma News
2010-2011
Women
Midwest 9.0 Men
15.6
Southeast 16.1
34.6
Southeast 11.4
21.4
Northeast 5.7
9.1
North 5.1
8.0
Data source: IDB (IBGE) Brasil 2011
20. Major Malignant Neoplasm by Gender
Data analysis: Brazil Pharma News
2010-2011
Esophagus
60.5
55.1 Stomach
53.8
49.3 Colon, rectum, rectosigmoid
junction, anus and anal canal
Female breast
Cervix
Prostate
Lip and oral cavity
18.5
14.3 13.7 14.8
Skin (melanoma)
10.6
8.1 7.7
Skin (non‐melanoma)
3.0 2.7 3.8 2.9
‐ ‐ ‐
Men Women
2010-2011 Incidence/100,000 inhabitants. Data source: IDB (IBGE) Brasil 2011
21. Transmissive Diseases Mortality Rate (2010)
Data analysis: Brazil Pharma News
Acute respiratory infections 29.4
AIDS 6.4
Sepsis, except neonatal 6.8
Meningitis 0.9
Diseases preventable by immunization 0.4
Vector‐borne diseases and rabies 3.2
Tuberculosis 2.4
Intestinal infectious diseases 2.4
Data source: IDB (IBGE) Brasil 2011
22. SUS hospitalization rate by disease groups (2010)
Data analysis: Brazil Pharma News
Malignat Neoplasm
Diabetes mellitus
22.6
Stroke
High blood pressure dieases
Ischemic heart diseases
39.9
Pneumonia
7.8
8.8
6.9
11.6
SUS: Unified Health System. Data source: IDB (IBGE) Brasil 2011
23. SUS Hospitalization rate due to external causes (2010)
Data analysis: Brazil Pharma News
Fall
Transport accidents
Intoxication
17.6 Assaults
19.1
Voluntary lesions
Other external causes
0.5
2.4
0.7
8.4
SUS: Unified Health System. Data source: IDB (IBGE) Brasil 2011
24. Prevalence of SUS dialysis patients
Data analysis: Brazil Pharma News
250.0
206.1
Up to 30 years
184.1
30 a 59 years
200.0
162.9
60 years or more
153.8
150.6
140.2
118.7
117.3
150.0
100.0
47.4
47.0
45.7
45.4
45.0
44.3
41.0
39.7
50.0
‐
‐
‐
‐
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
SUS: Unified Health System. Data source: IDB (IBGE) Brasil 2011